Your browser doesn't support javascript.
loading
Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells.
Angelos, Mathew G; Ruh, Paige N; Webber, Beau R; Blum, Robert H; Ryan, Caitlin D; Bendzick, Laura; Shim, Seonhui; Yingst, Ashley M; Tufa, Dejene M; Verneris, Michael R; Kaufman, Dan S.
Afiliação
  • Angelos MG; Division of Hematology, Oncology, and Transplantation, Department of Medicine.
  • Ruh PN; Stem Cell Institute.
  • Webber BR; Medical Scientist Training Program, and.
  • Blum RH; Division of Hematology, Oncology, and Transplantation, Department of Medicine.
  • Ryan CD; Stem Cell Institute.
  • Bendzick L; Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN.
  • Shim S; Division of Regenerative Medicine, Department of Medicine, University of California San Diego, La Jolla, CA; and.
  • Yingst AM; Division of Hematology, Oncology, and Transplantation, Department of Medicine.
  • Tufa DM; Stem Cell Institute.
  • Verneris MR; Division of Hematology, Oncology, and Transplantation, Department of Medicine.
  • Kaufman DS; Stem Cell Institute.
Blood ; 129(26): 3428-3439, 2017 06 29.
Article em En | MEDLINE | ID: mdl-28533309

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Hidrocarboneto Arílico / Células-Tronco Pluripotentes / Hematopoese Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Hidrocarboneto Arílico / Células-Tronco Pluripotentes / Hematopoese Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2017 Tipo de documento: Article